Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 27 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

6%

1 of 18 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment Performance

Analytics

N/A
9(56.3%)
Phase 2
5(31.3%)
Phase 3
1(6.3%)
Phase 1
1(6.3%)
16Total
N/A(9)
Phase 2(5)
Phase 3(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (27)

Showing 20 of 27 trials
NCT06593080Not ApplicableRecruiting

The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis

Role: collaborator

NCT05989802Not ApplicableRecruiting

Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)

Role: collaborator

NCT06064591Completed

Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX

Role: collaborator

NCT05002322Not ApplicableCompleted

Expanding Health Systems Research to Optimize Hypertension Care Cascade in HIV-Infected Individuals in Mozambique

Role: collaborator

NCT03313128Completed

SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance

Role: collaborator

NCT06747507Phase 3Recruiting

Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance

Role: collaborator

NCT06762054Recruiting

Investigating the Optimal Management of Dolutegravir Resistance

Role: collaborator

NCT05686356Phase 2Active Not Recruiting

A Pan-TB Regimen Targeting Host and Microbe

Role: collaborator

NCT06970600Not ApplicableCompleted

Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 12 Years at Four Sentinel Sites in Mozambique

Role: collaborator

NCT04568954Not ApplicableCompleted

TB-CAPT CORE Truenat Trial

Role: collaborator

NCT04568967Not ApplicableCompleted

TB-CAPT EXULTANT - HIV

Role: collaborator

NCT04442165Completed

Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique

Role: collaborator

NCT04066881Phase 2Completed

A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP

Role: collaborator

NCT04032522Completed

Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE)

Role: collaborator

NCT04303104Not ApplicableActive Not Recruiting

Xpert Active Case-finding Trial 3 (XACT-3)

Role: collaborator

NCT06326294Not ApplicableRecruiting

Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique

Role: lead

NCT05022407Completed

COVID-19 and HIV in Health Workers in Mozambique

Role: lead

NCT04027036Phase 2Completed

Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally

Role: lead

NCT05228639Completed

COVID-19 Surveillance in Rural Mozambique for Prompt and Effective Response

Role: collaborator

NCT03734172Completed

Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB)

Role: collaborator